Laboratory Research
Disconnecting multicellular networks in brain tumours
Varun Venkataramani*, Matthias Schneider*, Frank Anton Giordano, Thomas Kuner, Wolfgang Wick, Ulrich Herrlinger‡, Frank Winkler‡; * shared first authorship, ‡ shared senior authorship
Nature Reviews Cancer, 2022
Phase I/II trial of meclofenamate in progressive MGMT-methylated glioblastoma under temozolomide second-line therapy-the MecMeth/NOA-24 trial
Thomas Zeyen*, Anna-Laura Potthoff*, Robert Nemeth, Dieter H. Heiland, Michael C. Burger, Joachim P. Steinbach, Peter Hau, Ghazaleh Tabatabai, Martin Glas, Uwe Schlegel, Oliver Grauer, Dietmar Krex, Oliver Schnell, Roland Goldbrunner, Michael Sabel, Niklas Thon, Daniel Delev, Hans Clusmann, Clemens Seidel, Erdem Güresir, Matthias Schmid, Patrick Schuss, Frank A. Giordano, Alexander Radbruch, Albert Becker, Johannes Weller, Christina Schaub, Hartmut Vatter, Judith Schilling, Frank Winkler, Ulrich Herrlinger, Matthias Schneider; * shared first authorship,
Trials, 2022
Meclofenamate causes loss of cellular tethering and decoupling of functional networks in glioblastoma
Matthias Schneider*, Lea Vollmer*, Anna-Laura Potthoff*, Vidhya M Ravi, Bernd O Evert, Mohummad A Rahman, Shahin Sarowar, Jan Kueckelhaus, Paulina Will, David Zurhorst, Kevin Joseph, Julian P Maier, Nicolas Neidert, Paolo d'Errico, Melanie Meyer-Luehmann, Ulrich G Hoffmann, Andreas Dolf, Paolo Salomoni, Erdem Güresir, Per O Enger, Martha Chekenya, Torsten Pietsch, Patrick Schuss, Oliver Schnell, Mike-Andrew Westhoff, Jürgen Beck, Hartmut Vatter, Andreas Waha, Ulrich Herrlinger ‡, Dieter H Heiland ‡; * shared first authorship, ‡ shared senior authorship
Neuro-Oncology, 2021
Inhibition of Intercellular Cytosolic Traffic via Gap Junctions Reinforces Lomustine-Induced Toxicity in Glioblastoma Independent of MGMT Promoter Methylation Status
Matthias Schneider, Anna-Laura Potthoff, Bernd O Evert, Marius Dicks, Denise Ehrentraut, Andreas Dolf, Elena N C Schmidt, Niklas Schäfer, Valeri Borger, Torsten Pietsch, Mike-Andrew Westhoff, Erdem Güresir, Andreas Waha, Hartmut Vetter, Dieter H Heiland, Patrick Schuss ‡, Ulrich Herrlinger ‡, ‡ shared senior authorship
Pharmaceuticals, 2021
Inhibition of Gap Junctions Sensitizes Primary Glioblastoma Cells for Temozolomide
Anna-Laura Potthoff, Dieter Henrik Heiland, Bernd O. Evert, Filipe Rodrigues Almeida, Simon P. Behringer, Andreas Dolf, Ági Güresir, Erdem Güresir, Kevin Joseph, Torsten Pietsch, Patrick Schuss, Ulrich Herrlinger, Mike-Andrew Westhoff, Hartmut Vatter, Andreas Waha, Matthias Schneider
Cancers, 2019
A paired comparison between glioblastoma “stem cells” and differentiated cells
Matthias Schneider, Stephanie Ströbele, Lisa Nonnenmacher, Markus D. Siegelin, Melanie Tepper, Sebastien Stroh, Sebastian Hasslacher, Stefanie Enzenmüller, Gudrun Strauss, Bernd Baumann, Georg Karpel-Massler, Mike-Andrew Westhoff, Klaus-Michael Debatin, Marc-Eric Halatsch
International Journal of Cancer, 2015
